Wendell David Associates Inc Abb Vie Inc. Transaction History
Wendell David Associates Inc
- $990 Million
- Q1 2024
A detailed history of Wendell David Associates Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Wendell David Associates Inc holds 104,389 shares of ABBV stock, worth $17.9 Million. This represents 1.92% of its overall portfolio holdings.
Number of Shares
104,389
Previous 104,300
0.09%
Holding current value
$17.9 Million
Previous $16.2 Million
17.61%
% of portfolio
1.92%
Previous 1.74%
Shares
26 transactions
Others Institutions Holding ABBV
# of Institutions
3,651Shares Held
1.24BCall Options Held
15.5MPut Options Held
11.6M-
Vanguard Group Inc Valley Forge, PA170MShares$29.2 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY143MShares$24.5 Billion0.61% of portfolio
-
State Street Corp Boston, MA78MShares$13.4 Billion0.64% of portfolio
-
Jpmorgan Chase & CO New York, NY51.3MShares$8.79 Billion0.85% of portfolio
-
Capital International Investors Los Angeles, CA48.1MShares$8.25 Billion1.81% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $303B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...